๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-01-19

Caris Biorepository Research Protocol (NCT01499394)

The Caris Biorepository Research Protocol

๐ŸŸข Recruiting Interventional Protocol ๐Ÿ“Š Observational Clinical Research Sponsor: Caris Science, Inc.

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

The Biorepository for Caris Life Sciences is designed for the purpose of making quality biospecimens and associated clinical data available for research studies related to advancing precision medicine and improving care for patients. The Caris Biorepository is a repository of prospectively collected biological specimens and associated clinical and demographic data gathered from multiple sources to be stored, used and shared for research. Caris Life Sciences will maintain the data and specimens and will control access to and use of the information and specimens by multiple individuals for multiple purposes which may evolve over time.

Who can join: Review the eligibility criteria below.

Location: University of South Alabama โ€” Mobile, Alabama

Age range: 18 Years

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (38 Sites)

Showing the first 25 of 38 sites.

  • University of South Alabama โ€” Mobile, Alabama
  • Southwest Medical Imaging โ€” Scottsdale, Arizona
  • St. Bernards Medical Center โ€” Jonesboro, Arkansas
  • CARTI Cancer Center โ€” Little Rock, Arkansas
  • ObjectiveHealth - ARcare Center for Clinical Research โ€” Little Rock, Arkansas
  • Lee Memorial Health System โ€” Fort Myers, Florida
  • Cancer Care of North Florida โ€” Lake City, Florida
  • Advent Health โ€” Orlando, Florida
  • The University of South Florida โ€” Tampa, Florida
  • Cleveland Clinic Florida โ€” Weston, Florida
  • Phoebe Putney Memorial Hospital โ€” Albany, Georgia
  • Emory University โ€” Atlanta, Georgia
  • Augusta University Research Institute โ€” Augusta, Georgia
  • Cancer Center of Middle Georgia โ€” Dublin, Georgia
  • Hope and Healing Cancer Services โ€” Hinsdale, Illinois
  • CHRISTUS - St. Frances Cabrini Hospital โ€” Alexandria, Louisiana
  • Tulane University โ€” New Orleans, Louisiana
  • CHRISTUS - Highland Medical Center โ€” Shreveport, Louisiana
  • Mercy Medical Center โ€” Baltimore, Maryland
  • Sinai Hospital of Baltimore โ€” Baltimore, Maryland
  • Hattiesburg Clinic โ€” Hattiesburg, Mississippi
  • Jackson Oncology Associates โ€” Jackson, Mississippi
  • University of Mississippi Medical Center โ€” Jackson, Mississippi
  • ObjectiveHealth - Premier Health Research โ€” Sparta, New Jersey
  • CHRISTUS - St. Vincent Regional Cancer Center โ€” Santa Fe, New Mexico

๐Ÿ“ž Contact the Study Coordinator

Phone: (251) 445-3276

Email: tnfulford@health.southalabama.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Cancer clinical trials

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—